Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
复制标题
DOI:
10.1016/s0024-3205(97)00382-2
复制
发表时间:
1997-06
期刊:
影响因子:
6.1
通讯作者:
L. Mienie;J. Bergh;E. van Staden;S. Steyn;S. Pond;N. Castagnoli;C. J. Van der Schyf
中科院分区:
文献类型:
--
作者:
L. Mienie;J. Bergh;E. van Staden;S. Steyn;S. Pond;N. Castagnoli;C. J. Van der Schyf
Mounting evidence suggests that compromised cellular energy production is a major contributor to idiopathic and drug-induced degenerative processes. Our interest in neurotoxins have prompted us to examine in the baboon the effects of HPTP, the tetrahydropyridine dehydration product of haloperidol, on urinary chemical markers that reflect defects in mitochondrial respiration. Urinary dicarboxylic acid and conjugate profiles, similar to those seen in humans with inborn errors of mitochondrial metabolism and toxin-induced Jamaican vomiting sickness (JVS) were observed in the treated baboons. We interpret these results as evidence that HPTP and/or HPTP metabolites inhibit mitochondrial respiration in the baboon and speculate that analogous effects may occur in haloperidol-treated individuals.